MariMed Inc. (CSE:MRMD)

MariMed Statistics

Total Valuation

MariMed has a market cap or net worth of CAD 68.15 million. The enterprise value is 197.50 million.

Market Cap	68.15M
Enterprise Value	197.50M

Important Dates

The last earnings date was Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	392.31M
Shares Outstanding	n/a
Shares Change (YoY)	+2.01%
Shares Change (QoQ)	+1.92%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	351.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.32
PB Ratio	0.68
P/TBV Ratio	2.57
P/FCF Ratio	n/a
P/OCF Ratio	25.24
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.77, with an EV/FCF ratio of -65.26.

EV / Earnings	-9.09
EV / Sales	0.91
EV / EBITDA	9.77
EV / EBIT	144.25
EV / FCF	-65.26

Financial Position

The company has a current ratio of 1.12, with a Debt / Equity ratio of 1.19.

Current Ratio	1.12
Quick Ratio	0.27
Debt / Equity	1.19
Debt / EBITDA	5.94
Debt / FCF	-39.22
Interest Coverage	0.14

Financial Efficiency

Return on equity (ROE) is -19.76% and return on invested capital (ROIC) is 0.37%.

Return on Equity (ROE)	-19.76%
Return on Assets (ROA)	0.30%
Return on Invested Capital (ROIC)	0.37%
Return on Capital Employed (ROCE)	0.65%
Revenue Per Employee	276,929
Profits Per Employee	-28,081
Employee Count	832
Asset Turnover	0.76
Inventory Turnover	2.76

Taxes

In the past 12 months, MariMed has paid 12.45 million in taxes.

Income Tax	12.45M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.00% in the last 52 weeks. The beta is 3.02, so MariMed's price volatility has been higher than the market average.

Beta (5Y)	3.02
52-Week Price Change	-28.00%
50-Day Moving Average	0.12
200-Day Moving Average	0.15
Relative Strength Index (RSI)	66.07
Average Volume (20 Days)	80,574

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.04

Income Statement

In the last 12 months, MariMed had revenue of CAD 214.34 million and -21.73 million in losses. Loss per share was -0.06.

Revenue	214.34M
Gross Profit	82.73M
Operating Income	1.35M
Pretax Income	-9.22M
Net Income	-21.73M
EBITDA	17.13M
EBIT	1.35M
Loss Per Share	-0.06

Balance Sheet

The company has 8.37 million in cash and 118.69 million in debt, giving a net cash position of -110.32 million.

Cash & Cash Equivalents	8.37M
Total Debt	118.69M
Net Cash	-110.32M
Net Cash Per Share	n/a
Equity (Book Value)	99.80M
Book Value Per Share	0.21
Working Capital	8.44M

Cash Flow

In the last 12 months, operating cash flow was 2.70 million and capital expenditures -5.73 million, giving a free cash flow of -3.03 million.

Operating Cash Flow	2.70M
Capital Expenditures	-5.73M
Free Cash Flow	-3.03M
FCF Per Share	n/a

Margins

Gross margin is 38.60%, with operating and profit margins of 0.63% and -10.14%.

Gross Margin	38.60%
Operating Margin	0.63%
Pretax Margin	-4.30%
Profit Margin	-10.14%
EBITDA Margin	7.99%
EBIT Margin	0.63%
FCF Margin	n/a

Dividends & Yields

MariMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.01%
Shareholder Yield	n/a
Earnings Yield	-31.89%
FCF Yield	-4.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MariMed has an Altman Z-Score of 0.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.24
Piotroski F-Score	3